175 related articles for article (PubMed ID: 21297224)
1. Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.
Mahooti S; Porter K; Alpaugh ML; Ye Y; Xiao Y; Jones S; Tellez JD; Barsky SH
Oncotarget; 2010 Jun; 1(2):131-147. PubMed ID: 21297224
[TBL] [Abstract][Full Text] [Related]
2. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.
Tomlinson JS; Alpaugh ML; Barsky SH
Cancer Res; 2001 Jul; 61(13):5231-41. PubMed ID: 11431364
[TBL] [Abstract][Full Text] [Related]
3. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
4. Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma.
Alpaugh ML; Tomlinson JS; Kasraeian S; Barsky SH
Oncogene; 2002 May; 21(22):3631-43. PubMed ID: 12032865
[TBL] [Abstract][Full Text] [Related]
5. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
Ren S; Abuel-Haija M; Khurana JS; Zhang X
Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813
[TBL] [Abstract][Full Text] [Related]
6. Geometric tumor embolic budding characterizes inflammatory breast cancer.
Modi AP; Nguyen JPT; Wang J; Ahn JS; Libling WA; Klein JM; Mazumder P; Barsky SH
Breast Cancer Res Treat; 2023 Feb; 197(3):461-478. PubMed ID: 36473978
[TBL] [Abstract][Full Text] [Related]
7. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.
Arnaout-Alkarain A; Kahn HJ; Narod SA; Sun PA; Marks AN
Mod Pathol; 2007 Feb; 20(2):183-91. PubMed ID: 17206106
[TBL] [Abstract][Full Text] [Related]
8. The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype.
Xiao Y; Ye Y; Yearsley K; Jones S; Barsky SH
Am J Pathol; 2008 Aug; 173(2):561-74. PubMed ID: 18599608
[TBL] [Abstract][Full Text] [Related]
9. Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7.
Ye Y; Gao JX; Tian H; Yearsley K; Lange AR; Robertson FM; Barsky SH
Mol Cancer Res; 2012 Jun; 10(6):713-26. PubMed ID: 22638108
[TBL] [Abstract][Full Text] [Related]
10. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis.
Marinho VF; Metze K; Sanches FS; Rocha GF; Gobbi H
BMC Cancer; 2008 Feb; 8():64. PubMed ID: 18307818
[TBL] [Abstract][Full Text] [Related]
11. Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis.
Morales J; Alpaugh ML
BMC Cancer; 2009 Dec; 9():462. PubMed ID: 20028562
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking.
Ye Y; Tellez JD; Durazo M; Belcher M; Yearsley K; Barsky SH
Anticancer Res; 2010 Oct; 30(10):3903-10. PubMed ID: 21036701
[TBL] [Abstract][Full Text] [Related]
13. Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.
Alpaugh ML; Tomlinson JS; Ye Y; Barsky SH
Am J Pathol; 2002 Aug; 161(2):619-28. PubMed ID: 12163386
[TBL] [Abstract][Full Text] [Related]
14. The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin.
Ye Y; Tian H; Lange AR; Yearsley K; Robertson FM; Barsky SH
Oncogene; 2013 Mar; 32(13):1702-13. PubMed ID: 22580607
[TBL] [Abstract][Full Text] [Related]
15. D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients.
Gudlaugsson E; Skaland I; Undersrud E; Janssen EA; Søiland H; Baak JP
Mod Pathol; 2011 Apr; 24(4):502-11. PubMed ID: 21317878
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic microvessel density as prognostic marker in colorectal cancer.
Saad RS; Kordunsky L; Liu YL; Denning KL; Kandil HA; Silverman JF
Mod Pathol; 2006 Oct; 19(10):1317-23. PubMed ID: 16799477
[TBL] [Abstract][Full Text] [Related]
17. D2-40 in breast cancer: should we detect more vascular emboli?
de Mascarel I; MacGrogan G; Debled M; Sierankowski G; Brouste V; Mathoulin-Pélissier S; Mauriac L
Mod Pathol; 2009 Feb; 22(2):216-22. PubMed ID: 18820667
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters.
El-Gendi S; Abdel-Hadi M
J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
[TBL] [Abstract][Full Text] [Related]
20. Epithelial displacement into the lymphovascular space can be seen in breast core needle biopsy specimens.
Koo JS; Jung WH; Kim H
Am J Clin Pathol; 2010 May; 133(5):781-7. PubMed ID: 20395526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
